Success Stories: EB-1A Approved for a Research Fellow in Massachusetts in the Field of Medical Biology

Client’s Testimonial:

 

Thanks a lot for your kind help! I will definitely recommend your firm. Thanks again!

 


On March 25th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Research Fellow in the Field of Medical Biology (Approval Notice)


General Field: Medical Biology

Position at the Time of Case Filing: Research Fellow

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date:  March 25th, 2015

Processing Time:  23 days (9 days after Requesting Premium Processing)

 

 


Case Summary:

In this case, the client that we had the opportunity to work with was a research fellow from China in the field of medical biology.  He had conducted his research in the highly specialized area of risk factors associated with conditions such as gastric cancer and gastroesophageal reflux disease, as well as on the design, development, and commercialization of next-generation sequencing methods. His work had resulted in 26 peer-reviewed scientific articles, 3 patents, and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 690 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work.  He had also reviewed 18 manuscripts for distinctive, internationally-circulated journals.  His superior level of expertise was confirmed in the following quote from an independent recommender, “There are very few researchers in any area of science who can boast a record like [Client’s]. Replacing him would be a monumental challenge indeed.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of medical biology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 23 days (9 days after requesting Premium Processing).